Folic acid: Nutritional biochemistry, molecular biology, and role in disease processes

Molecular Genetics and Metabolism

Volumn 71, Issue 1-2, 2000, Pages 121-138

  Lucock, Mark ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME; FOLIC ACID; FOLINIC ACID; GLYCINE; HISTIDINE; HOMOCYSTEINE; METHIONINE; NUCLEOTIDE; PURINE; PYRIMIDINE; SERINE;

AFFECTIVE NEUROSIS; BIOSYNTHESIS; CANCER; CARCINOGENESIS; CARDIOVASCULAR DISEASE; DEMENTIA; DIET; DIET SUPPLEMENTATION; DISEASE COURSE; DOWN SYNDROME; DRUG ABSORPTION; DRUG EFFECT; DRUG STRUCTURE; DRUG TRANSPORT; ENZYME POLYMORPHISM; FOLATE METABOLISM; FOLIC ACID DEFICIENCY; GENETIC VARIABILITY; HUMAN; MOLECULAR BIOLOGY; NEURAL TUBE DEFECT; NONHUMAN; NUTRITION; PATHOGENESIS; PREGNANCY COMPLICATION; PRIORITY JOURNAL; SHORT SURVEY; VITAMIN SUPPLEMENTATION;

EID: 0033808685     PISSN: 10967192     EISSN: None     Source Type: Journal    
DOI: 10.1006/mgme.2000.3027     Document Type: Article

References (135)

1. Treatment of pernicious anaemia of pregnancy and tropical anaemia with special reference to yeast extract as curative agent
2. The structuresynthesis of the liver L.casei factor
3. The concentration of 'folic acid'
4. Folic acid concentration from spinach
5. Serum folates in man
6. Folic acid metabolism
7. The pteroylglutamate components of American diets as determined by chromatographic fractionation
8. Naturally occuring forms of folic acid. III. Characterisation and properties of 5-methyldihydrofolate, an oxidation product of 5-methyltetrahydrofolic acid
9. Nonenzymatic degradation and salvage of dietary folate: Physicochemical factors likely to influence bioavailability
10. Studies on the identification of a folate compound of human serum
11. A rapid and specific HPLC-electrchemical method for the determination of endogenous 5-Methyltetrahydrofolic acid in plasma using solid phase sample preparation with internal standardization
12. Mammalian folyl-γ-glutamate synthetase, 4. In vitro and in vivo metabolism of folates and analogues and regulation of folate homeostasis
13. Folylpolyglutamates as substrates and inhibitors of folate-dependent enzymes
14. Methionine biosynthesis
15. Mechanisms of folate homeostasis
16. Pteroylglutamic acid (PGA) activity of serum in gel filtration
17. Carrier proteins of folic acid activity in human serum
18. New carrier protein(s) of folic acid activity in human serum
19. Transferrin the third carrier protein of folic acid activity in human serum
20. Serum folate activity (L.casei) in sephadex gel chromatography
21. 12 and folic acid
22. Characteristics of folic acid binding protein in folate deficient serum
23. Appearance of a folate binder in leukocytes and serum of women who are pregnant or are taking oral contraceptives
24. Further observations on the folate binding factor in some leukaemic cells
25. Abnormal folate binding proteins in azotemic patients
26. Evidence for granolocyte related and liver related folate binders in human serum and renal glomerular filtration of folate binder
27. Purification of folate binding factor in normal umbilical cord serum
28. The folate binding protein of rat kidney: Purification, properties and cellular distribution
29. Studies of the role of a particulate folate-biding protein in the uptake of 5-methyltetrahydrofolate by cultured human KB cells
30. The interrelationship of the soluble and membrane associated folate binding proteins in human KB cells
31. Blood folic acid studies. VII. Purification and properties of the folic acid precursors of human erythrocytes
32. Folic acid and unconjugated pteridines
33. Evidence that 5-formyltetrahydropteroylglutamate has a metabolic role in one-carbon metabolism
34. Altered folate metabolism and disposition in mothers affected by a spina bifida pregnancy: Influence of 677c → t methylenetetrahydrofolate reductase and 2756a → g methionine synthase genotypes
35. 12 in folate coenzyme synthesis
36. Proteins involved in the transport of folates and antifolates by normal and neoplastic cells
37. Transport of 5-methyltetrahydrofolic acid and folic acid in fleshly prepared hepatocytes
38. Transport of 5-methyltetrahydrofolic acid in basolateral membrane vesicles from human liver
39. 5-Methyltetrahydrofolic acid transport in basolateral membrane vesicles from human liver
40. A carrier mediated transport for folate in basolateral membrane vesicles of rat small intestine
41. Folate binding protein from kidney brush border membranes contains components of a glycoinositol phospholipid anchor
42. Cellular localisation of the folate receptor: Potential role in drug toxicity and folate homeostasis
43. Internalisation and intracellular transport of folate-binding protein in rat kidny proximal tubule
44. The glycophospholipid linked folate receptor internalises folate without entering the clathrin coated pit endocytic pathway
45. Cobalamin-dependent methionine synthase
46. Folylpolyglutamate synthesis and role in the regulation of one-carbon metabolism
47. Interactions of pig liver methylenetetrahydrofolate reductase with methylenetetrahydropteroylpolyglutamate substrates and with dihydropteroylpolyglutamate inhibitors
48. Substrate flux through methylenetetrahydrofolate dehydrogenase: Predicted effects of the concentration of methylenetetrahydrofolate on its partitioning into pathways leading to nucleotide biosynthesis or methionine regeneration
49. Biochemical role of folate in cellular metabolism
50. The metabolic role of leucovorin
51. The pathogenesis of homocysteinemia: Interruption of the coordinate regulation by s-adenosylmethionine of the remethylation and transsulphuration of homocysteine
52. Examination of the role of methylenetetrahydrofolate reductase in incorporation of methyltetrahydrofolate into cellular metabolism
53. Cloning and mapping of a cDNA for methionine synthase reductase, a flavoprotein defective in patients with homocystinuria
54. Methionine metabolism in mammals
55. Methionine metabolism in mammals: The biochemical basis for homocystinuria
56. Activation of cystathionine synthase by adenosylmethionine and adenosylethionine
57. Methionine metabolism in mammals: Distribution of homocysteine between competing pathways
58. Methionine metabolism in mammals: Adaptation to methionine excess
59. Mammalian methylenetetrahydrofolate reductase: Partial purification, properties, and inhibition by S-adenosylmethionine
60. Inhibition of glycine N-methyltransferase by folate derivatives: Implications for regulation of methyl group metabolism
61. Interractions of pig liver serine hydroxymethyltransferase with methyltetrahydropteroyl polyglutamate inhibitors and with tetrahydropteroylpolyglutamate substrates
62. Prevention of neural tube defects: Results of the Medical Research Council Vitamin Study
63. Prospective study of serum total homocysteine concentrations and risk of stroke in middle aged British men
64. Plasma homocysteine as a risk factor for atherothrombotic events in systematic lupus erythematosus
65. Carotid artery intimal-medial thickening and plasma homocysteine in asymptomatic adults: The atherosclerosis risk in communities study
66. Association between plasma homocysteine concentration and extracranial carotid-artery stenosis
67. Methylenetetrahydrofolate reductase thermolabile variant and oral clefts
68. Folate status, women's health, pregnancy outcome and cancer
69. Experimental study of the therapeutic effects of folate, vitamin A and vitamin B12 on squamous metaplasia of the bronchial epithelium
70. Methylenetetrahydrofolate reductase, diet, and risk of colon cancer
71. A prospective study of folate intake and the risk of breast cancer
72. Folate, vitamin B12 and serum total homocysteine levels in confirmed alzheimers disease
73. Enhacement of recovery from psychiatric illness by methylfolate
74. Abnormal folate metabolism and mutation in the methylenetetrahydrofolate reductase gene may be maternal risk factors for Down's syndrome
75. Underlying disorders associated with severe early onset preeclampsia
76. Elevated homocyst(e)ine levels with preeclampsia
77. Metabolic abnormalities detected in a survey of mentally backward individuals in Northern Ireland
78. Homocystinuria: An enzymatic defect
79. Disorders of transsulfuration
80. Homocystinemia vascular injury and arterial thrombosis
81. Plasma homocysteine and cardiovascular disease
82. Can lowering homocystine levels reduce cardiovascular risk
83. Folic acid: An innocuous means to reduce plasma homocysteine
84. The responsiveness of plasma homocysteine to small increases in dietary folic acid: A primary care study
85. Nutritional ecogenetics: Homocysteine related arteriosclerotic vascular disease, neural tube defects and folic acid
86. Prospective studies of homocysteine and cardiovascular disease
87. Relation of serum homocysteine and lipoprotein (A) concentrations to atherosclerotic disease in a prospective Finnish population based study
88. Homocysteine and hypomethylation, a novel link to vascular disease
89. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase
90. The structure and properties of methylenetetrahydrofolate reductase from E. coli suggest how folate ameliorates human hyperhomocysteinemia
91. Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease-the result of a meta-analysis
92. Hyperhomocysteinemia in terms of steady state kinetics
93. Thermolabile methylenetetrahydrofolate reductase: An inherited risk factor for coronary heart disease
94. A prospective study of plasma homocysteine and risk of myocardial infarction in US physicians
95. Polymorphisms of methyleneterahydrofolate reductase and other enzymes: Metabolic significance, risks and impact on folate requirement
96. Prevention of the first occurrence of neural tube defects by periconceptional vitamin supplementation
97. Double-blind randomised controlled trial of folate treatment before conception to prevent recurrence of neural-tube defects
98. Further experience of vitamin supplementation for prevention of neural tube defect recurrences
99. A randomised trial of low dose folic acid to prevent neural tube defects
100. Maternal plasma folate and vitamin B12 are independent risk factors for neural tube defects
101. 12) in amniotic fluid
102. A genetic defect in 5,10 methylenetetrahydrofolate reductase in neural tube defects
103. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida
104. Impaired regeneration of monoglutamyl tetrahydrofolate leads to cellular folate depletion in mothers affected by a spina bifida pregnancy
105. Homocysteine and neural tube defects
106. Sequence analysis of the coding region of human methionine synthase: Relevance to hyperhomocysteinaemia in NTD and vascular disease
107. Methionine synthase and neural tube defects
108. Methionine synthase D919G polymorphism is a significant but modest determinant of circulating homocysteine concentrations
109. A second common mutation in the methylenetetrahydrofolate reductase gene: An additional risk factor for neural tube defects?
110. A common variant in methionine synthase reductase combined with low cobalamin (vitamin B12) increases risk for spina bifida
111. 5,10 Methylenetetrahydrofolate reductase C677T Genotypes and folate related risk factors for neural tube defects
112. Spina bifida, 677ct mutation and role of folate
113. Methylenetetrahydrofolate reductase and neural tube defects
114. Molecular genetic analysis of the gene encoding the trifunctional enzyme MTHFD (methylenetetrahydrofolate-deydrogenase, methenyltetrahydrofolate-cyclohydrolase, formyltetrahydrofolate-synthetase) in patients with neural tube defects
115. Nutritional supplementation and prevention of congenital abnormalities
116. Transcriptional repression by methylation cooperativity between a CpG cluster in the promoter and remote CpG-rich regions
117. DNA instability (strand breakage, uracil misincorporation, and defective repair) is increased by folic acid depletion in human lymphocytes in vitro
118. Methylenetetrahydrofolate reductase polymorphism, dietary interractions and risk of colorectal cancer
119. Polymorphisms in the methylenetetrahydrofolate reductase gene are associated with susceptibility to acute leukemia in adults
120. A prospective study on folate, B12, and pyridoxal 5'-phosphate (B6) and breast cancer
121. Familial clustering of neural tube defects and gastric cancer
122. The relationship between maternal and neonatal umbilical cord plasma Hcy suggests a potential role for maternal Hcy in fetal metabolism
123. Maternal plasma Hcy, placenta status docosahexanoic acid concn in erythrocyte phospholipids of the newborn
124. Vitamin A, folate, and iron concentrations in cord and maternal blood of intra-uterine growth retarded and appropriate birth weight babies
125. Serum concentrations of zinc, folate, vitamins A and E, and proteins, and their relationships to pregnancy outcome
126. Hyperhomocysteinemia: A risk factor for placental abruption
127. Hyperhomocysteinaemia and protein S deficiency in complicated pregnancies
128. Intrauterine origins of cardiovascular and obstructive lung disease in adult life
129. Methylenetetrahydrofolate reductase polymorphism and pre-eclampsia
130. Genetic risk factor for unexplained recurrent early pregnancy loss
131. The methyl folate trap
132. In vivo characterisation of the absorption and biotransformation of pteroylglutamic acid in man: A model for future studies
133. Unmetabolised folic acid in serum: Acute studies in subjects consuming fortified food and supplements